Sun Pharma Corporate Overview
US Business at a glance
10th Largest Pharma Company in the US Generics Market
*
Dermatology Segment
•
Ranked 2nd by prescriptions## in the US dermatology market
Comprehensive Portfolio**
•
Robust Pipeline**
Market Presence
SUN
PHARMA
Wide basket of 595 ANDAS & 64 NDAs filed and 501 ANDAS & 55
NDAS approved across multiple therapies
• 94 ANDAS & 9 NDAs pending with FDA
• Presence in generics, branded & OTC segments
Flexible Manufacturing
Dosage Forms
**All data as of 31-March-2021
• Integrated manufacturer with flexibility for manufacturing
onshore/ offshore
Liquids, Creams, Ointments, Gels, Sprays, Injectable, Tablets,
Capsules, Drug-Device combination
* Source: IQVIA data for 12 months ended Feb 2021
## Source: IQVIA data for 12 months ended Feb 2021
© Sun Pharmaceutical Industries Limited. All Rights Reserved.
18View entire presentation